Browse Category

Health Insurance News 4 December 2025 - 21 December 2025

UnitedHealth Group (UNH) Stock Week Ahead: Audit Overhaul, Trump’s Insurer Price Talks, and ACA Subsidy Deadline Drive the Outlook

UnitedHealth Group (UNH) Stock Week Ahead: Audit Overhaul, Trump’s Insurer Price Talks, and ACA Subsidy Deadline Drive the Outlook

As of December 21, 2025, UnitedHealth Group Incorporated (NYSE: UNH) heads into a holiday-shortened trading week with investors balancing a familiar mix of catalysts: regulatory and political headlines, ongoing scrutiny of Medicare Advantage practices, legal overhangs tied to Optum, and
UnitedHealth Group Stock (UNH) After Hours: Trump Premium Comments, New Audit “Action Plans,” and What to Watch Before the Next Market Open

UnitedHealth Group Stock (UNH) After Hours: Trump Premium Comments, New Audit “Action Plans,” and What to Watch Before the Next Market Open

NEW YORK — December 19, 2025 (after the close) — UnitedHealth Group Incorporated (NYSE: UNH) finished Friday’s session close to flat after a sharp, headline-driven swing, then drifted modestly in after-hours trading. Two stories dominated the tape into the closing
UnitedHealth Group Incorporated Stock (NYSE: UNH) News Today: Audit-Driven Overhaul, OptumRx Shift, and 2026 Forecasts (Dec. 19, 2025)

UnitedHealth Group Incorporated Stock (NYSE: UNH) News Today: Audit-Driven Overhaul, OptumRx Shift, and 2026 Forecasts (Dec. 19, 2025)

UnitedHealth Group Incorporated (NYSE: UNH) stock traded higher on Friday, December 19, 2025, as investors digested a fresh set of operational updates tied to external audits—and weighed what those changes could mean for 2026 performance, regulatory scrutiny, and margins across
UnitedHealth Group Stock (UNH) News Today, Dec. 18, 2025: Policy Risk, Optum Rx Changes, and Wall Street Forecasts

UnitedHealth Group Stock (UNH) News Today, Dec. 18, 2025: Policy Risk, Optum Rx Changes, and Wall Street Forecasts

UnitedHealth Group Incorporated (NYSE: UNH) stock is ending a volatile 2025 with fresh headline risk—and a handful of potentially meaningful catalysts—front and center on December 18, 2025. Shares traded around $326–$327 in midday trading, after moving between roughly $324.66 and
UnitedHealth Group (UNH) Stock This Week: DOJ-Amedisys Final Judgment, Fresh Legal Risks, Analyst Forecasts, and What to Watch Next Week (Updated Dec. 12, 2025)

UnitedHealth Group (UNH) Stock This Week: DOJ-Amedisys Final Judgment, Fresh Legal Risks, Analyst Forecasts, and What to Watch Next Week (Updated Dec. 12, 2025)

UnitedHealth Group Incorporated (NYSE: UNH) finished the week with a notable rebound, closing Friday, December 12, 2025 at $341.84, up 1.52% on the day—outperforming a broader market that sold off into the weekend. Investing.com+1 The move capped a choppy five-session
UnitedHealth (UNH) Stock After Hours on Dec. 12, 2025: Earnings Date Set, Policy Catalysts, and What to Watch Next

UnitedHealth (UNH) Stock After Hours on Dec. 12, 2025: Earnings Date Set, Policy Catalysts, and What to Watch Next

UnitedHealth Group Incorporated (NYSE: UNH) ended the Friday, December 12, 2025 session on a relative high note—rising even as the broader market slid—and then traded modestly lower in the first hour of after-hours action. StockAnalysis+1 If you’re tracking UNH into
Elevance Health Stock (NYSE: ELV) News Today: Credit Ratings, ACA Subsidy Vote, and Analyst Forecasts on Dec. 12, 2025

Elevance Health Stock (NYSE: ELV) News Today: Credit Ratings, ACA Subsidy Vote, and Analyst Forecasts on Dec. 12, 2025

Elevance Health, Inc. (NYSE: ELV) is drawing fresh investor attention on December 12, 2025 as credit-rating updates and U.S. policy headlines collide with a stock that has recently rebounded sharply. The latest developments arrive at a sensitive moment for managed-care
Elevance Health (ELV) Stock News Today: ACA Subsidy Deadline Looms, Fitch Affirms A- Rating, and Analysts See Modest Upside (Dec. 12, 2025)

Elevance Health (ELV) Stock News Today: ACA Subsidy Deadline Looms, Fitch Affirms A- Rating, and Analysts See Modest Upside (Dec. 12, 2025)

Elevance Health (NYSE: ELV) is stabilizing near the $360 level after a sharp rebound, while Washington’s failure to extend ACA subsidies raises new 2026 uncertainty. Here’s the latest news, credit outlook, analyst forecasts, and technical setup as of December 12,
UnitedHealth Group (UNH) Stock News Today: DOJ Amedisys Ruling, Optum Lawsuit Risks, and Analyst Forecasts (Dec. 12, 2025)

UnitedHealth Group (UNH) Stock News Today: DOJ Amedisys Ruling, Optum Lawsuit Risks, and Analyst Forecasts (Dec. 12, 2025)

UnitedHealth Group Incorporated (NYSE: UNH) stock is back in focus on December 12, 2025, after a strong Thursday rebound put the health-insurance giant near a closely watched technical zone around $340—while investors continue to weigh a busy mix of antitrust
Oscar Health (OSCR) Stock Today: Fresh Analyst Coverage, Big 2027 Profit Hopes and Policy Risk in Focus

Oscar Health (OSCR) Stock Today: Fresh Analyst Coverage, Big 2027 Profit Hopes and Policy Risk in Focus

Oscar Health, Inc. (NYSE: OSCR) is back under the market’s spotlight on December 11, 2025, as Wall Street adds new coverage, doubles down on long‑term profit targets, and investors digest another bout of volatility in this high‑growth, high‑risk health‑insurtech name.
Humana Stock (HUM) Outlook December 4, 2025: Earnings Beat, Legal Risks and 2026 Medicare Advantage Forecast

Humana Stock (HUM) Outlook December 4, 2025: Earnings Beat, Legal Risks and 2026 Medicare Advantage Forecast

Date: December 4, 2025Ticker: Humana Inc. (NYSE: HUM) Humana’s share price spent most of 2025 behaving like a stressed-out cardiogram: sharp drops around guidance cuts and star-rating headlines, then sharp rebounds when the numbers looked less bad than feared. As
1 2 3
Go toTop